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Abstract
Background: Anelloviruses (TTV, TTMV, and TTMDV) have been associated with non A-G hepatitis. The goal of the
current study was to estimate the prevalence of these anelloviruses in Qatar.
Methods: A total of 607 blood samples (500 healthy donors, and 53 HBV-and 54 HCV-positive patients)
representing different nationalities were tested for the presence of TTV, TTMV, and TTMDV DNA by nested PCR.
Results: Prevalence rates for the three viruses were high in all studied groups, and exceeding 95% in the HBV
group (for TTV and TTMDV). Infection with more than one type of viruses was common and significant in most of
the positive patients (p < 0.05) and ranging from 55.4% for TTV/TTMV and TTMV/TTMDV co-infections in the healthy
group, to 96.3% for TTV/TTMV co-infections in the HBV group. Further, and as with most previous studies, no
significant association was found between anelloviruses infections and age, nationality, or gender (p > 0.05) albeit
the detection of higher infection rates among females and Qatari subjects.
Conclusion: This was the first published study to look at prevalence of Anellowviruses in the Middle East. High
prevalence rates of the three viruses in all studied groups was noted. Further studies are needed to explore and
compare the different genotypes of these viruses in the region.
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Background
Human infections with anelloviruses (small ssDNA vi-
ruses) are widely spread [1, 2]. A prominent member of
the Anelloviridae family is the Torque teno virus (TTV),
reported for the first time in 1997 in a Japanese patient
with post-transfusion hepatitis of unknown etiology [3].
Subsequently (in 2000), another small DNA virus, desig-
nated Torque teno mini virus (TTMV), remotely similar
to TTV was discovered [4]. In 2007 a third addition to
the anellovirus genus was reported; the new virus had a
genome of 3.2 kb (TTV and TTMV were around 3.8
and 2.8 kb, respectively), hence the designation Torque
teno midi virus (TTMDV) [5]. The Anelloviridae family
contains 12 genera; TTV, TTMV, and TTMDV belong
to Alphatorquevirus, Betatorquevirus, and Gammator-
quevirus, genera respectively [6].
The Alphatorquevirus genera (TTV) alone has 29 spe-
cies. Much less is known about phylogenetic groups for
TTMV and TTMDV [7]; TTMV ORF1 sequence com-
parison showed significant divergence, and complete
genome analysis of TTMDV also shows sequences clus-
tering [7].
The three viruses share a similar genome organization
(UTR region, open reading frame region followed by
short G/C rich region). Further, the three viruses are ex-
tremely divergent in the ORF regions both at the nucleo-
tide and amino acid levels [6].
Furthermore, infection with anelloviruses can be
highly common reaching a 90% prevalence rate [8]. Re-
ports on the prevalence of TTMV in humans indicated
high rates of infection in French [9], Brazilian [10, 11]
and in Norwegian [12] blood donors and also in French
hemodialysis patients (95%) [13]. Further, TTMV DNA
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has been detected in amniotic fluid, cord blood and
breast milk [10, 14]. TTMV DNA has also been detected
in cervical swabs of healthy women [15], women diag-
nosed with cervical cancers, peripheral blood mono-
nuclear cells, feces and saliva [16].
TTMDV DNA was detected in plasma and saliva sam-
ples of French blood donors [17], in healthy and hepa-
titis C Italian serum samples [18], in healthy blood
donors, hepatitis C patients and HIV patients in Iran
[19], and in Korean chronic hepatitis patients and blood
products [20]. TTMDV was also reported in Hungarian
children with acute respiratory disease [21].
Since TTV was first detected in blood samples it was
referred to as transfusion-transmitted (TT) virus [3].
Subsequent studies suggested the existence of other
ways of TTV transmission including parenteral, sexual,
vertical and others [22].
TTV has been detected in almost every human tissue
type or body fluid, the newly discovered TTMV can be
transmitted from mother to baby; similar virus se-
quences in mother and baby were detected in umbilical
cord blood, breast milk, amniotic fluid, and sera of new-
borns [7].
Finally, viremic infections with multiple genotypes of
any of the three viruses at any one time is not uncom-
mon [12, 17, 23].
The aim of the current study was to investigate the
rates of infection of TTV, TTMV, and TTMDV in Qatar,
and to examine the association of these virus infections,
if any, with HBV or HCV.
Methods
Ethical approval
Prior to samples collection from patients and blood donors,
Institutional Review Board of Hamad Medical Corporation
(HMC) (Protocol No.13422/13) and Qatar University (IRB
No. QU-IRB289-A/14) approvals were obtained. Further-
more, because this research involves no risk to the partici-
pants, a waiver of all the consent requirements was
obtained. The participants’ rights and welfare were not
harmfully affected, because personal information related to
participants was not claimed. Blood samples obtained from
the blood bank and the hospital were anonymous. The only
information collected related to the participants were na-
tionality, sex, and age. Information concerning collected
data was kept confidential.
Blood samples collection
The samples that were used in this project to detect
TTMDV and TTMV DNA were exactly the same ones
we used in our previous TTV published project [8], and
the data from it were used again in this study for com-
parison purposes between the three anelloviruses.
A total of 500 samples from healthy blood donors
were used in the present study. These samples were col-
lected from the blood donation unit during the period
from June to August 2013. In addition, blood samples
from 54 infected HBV to 53 HCV patients were also ob-
tained from the diagnostic virology laboratory at the
HMC.
Plasma DNA extraction
DNA was extracted from 200 μl aliquots of plasma using
a standard commercial kit for viral DNA extraction from
body fluids (PureLink® Viral RNA/DNA Kits - Life Tech-
nologies; Grand Island, New York, USA).
Whole genome amplification of DNA
Due to small sample volume, extracted DNA was ampli-
fied using REPLI-g Mini Kit (Catalog # 150025, Qiagen,
USA) following manufacturer’s protocol. Amplified DNA
was stored at −20 °C until use.
Detection of TTMDV and TTMV
Both viruses were detected using nested PCR. For the
first round PCR setup, the following components were
used: one μl of whole genome amplified DNA, 10 pmol
each of forward and reverse primers (universal primers)
as described previously [24] and GoTaq Green Master
Mix (Promega, Madison, WI, USA) in a reaction volume
of 50 μl (μl). The mixture was preheated at 95°C for
5 min followed by 35 cycles with parameters as follows:
95°C for 30 s, 55°C for 30 s, 72°C for 30 s, and a final ex-
tension of 72 °C for 5 min. For the second round, two
PCR reactions to detect TTMDV and TTMV were sep-
arately prepared. For the detection of TTMDV, the reac-
tion mixture consisted of 5 μl of the amplification
product of the first round, 15 pmol of NG795/NG796
primers [24] and GoTaq Green Master Mix with a total
volume of 40 μl. The mixture was preheated at 95°C for
5 min followed by 30 cycles of 95°C for 20 s, 62°C for
20 s, 72°C for 20 s, and a final extension of 72°C for
5 min. The same conditions were used to detect TTMV
except that the primers NG792/NG793/NG794 as sense
primers and NG791 as antisense primer were used [24].
Fifteen μl of the amplified products were electropho-
resed in 2.5% agarose gel, stained with GreenView Plus
(GeneCopoeia, USA), and photographed under UV light.
Statistical analysis
Data were analyzed using SPSS software. The chi-square
test was used to compare proportions between the
groups. Differences were considered to be statistically
significant at was p < 0.05.
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Results
Study population analysis
In the present study, a total of 607 plasma samples were
screened for the presence of anellovirsuses (TTV,
TTMDV, TTMV) DNA using nested PCR. The majority
of samples were from healthy blood donors and non-
Qatari male nationals. Age, gender and nationality distri-
butions were not significantly different in healthy blood
donors and HBV- or HCV-positive patients. Blood do-
nors in Qatar were predominantly males, and so did
those tested positive for HBV and HCV. It should be
noted that the expatriate population makes up the vast
majority of residents in Qatar with about only 16% of
those residing in Qatar are Qatari nationals. Our study
population reflects the demographic distribution in the
population. In terms of age, it appears that the majority
of the HBV patients were younger than 30 years whilst
the majority of HCV patients were older than 50 years
as was shown in Table 1.
Anelloviruses infection rates in the different populations
In order to determine the rate of infection of the three anel-
loviruses, plasma DNA was extracted from a total of 607
blood samples representing healthy blood donors (n = 500),
HBV (n = 54), and HCV (n = 53) -infected patients residing
in Qatar, and DNA of each virus was screened by nested
PCR as described in the Methods. Figure 1 depicts the
prevalence of TTV, TTMDV and TTMV DNA among the
overall studied population. The overall prevalence of TTV
DNA (85.2%) was significantly (p <0.001) higher than
TTMDV (76.3%), and TTMV (66.6%). Further, TTV preva-
lence was significantly (p <0.001) higher among the healthy
donor population than TTMDV and TTMV (Table 2).
We also noticed that patients co-infected with HBV or
HCV showed significantly (p <0.05) higher infection
rates with anelloviruses than the healthy blood donors.
The only exception was in the insignificant association
between TTV and HCV infection. A closer look at
Table 2 revealed that the highest prevalence of the three
viruses was among the HBV followed by the HCV- in-
fected patients.
Analysis of mixed infections
Our data also showed that co-infections between the
three anelloviruses was also very common (Table 3). The
study found that 67.2% of healthy blood donors were in-
fected with both TTV and TTMDV (p <0.001), and
55.4% were infected with TTV and TTMV or TTMDV
and TTMV (p <0.001). The co-infection rates were sig-
nificantly higher in blood donors (p < 0.001); there was
no significant association between infections with any of
TTV and TTMDV, TTV and TTMV or TTMDV and
TTMV among HBV or HCV-infected patients.
Table 1 Characteristics of the subjects (n = 607)
Healthy (n = 500) n (%) HBV (n = 54) n (%) HCV (n = 53) n (%)
Gender Male 488 (97.6) 39 (72.2) 39 (73.6)
Female 12 (2.4) 15 (27.8) 14 (26.4)
Nationality Qatari 60 (12.0) 9 (16.7) 12 (22.6)
Non-Qatari 440 (88.0) 45 (83.3) 41 (77.4)
Age (years) <30 122 (24.4) 22 (40.7) 9 (17.0)
31–40 227 (45.4) 18 (33.3) 9 (17.0)
41–50 108 (21.6) 6 (11.1) 12 (22.6)
>51 43 (8.6) 8 (14.8) 23 (43.4)
Age range (Average ± SD) 13 − 80 (36 ± 10.6) 19 − 74 (36 ± 9.3) 13 − 74 (34.9 ± 12.0) 15 − 80 (45 ± 14.9)
Fig. 1 Prevalence of TTV, TTMDV, and TTMV in the overall study
population (n = 607) * Significant difference (p < 0.05)
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The distribution of infection with TTV, TTMDV, or
TTMDV among different nationalities, ages, and gender
was shown in Table 4; there was no significant associ-
ation between infection with TTV, TTMDV, or TTMDV
and age or gender.
Furthermore, since the expatriate population makes up
the vast majority of residents in Qatar, we sought to study
the distribution of the three anelloviruses in different na-
tionalities residing in Qatar (Tables 2 and 5). As shown in
Table 2, although the Qatari population had the highest
prevalence of the three anelloviruses, the difference was
not statistically significant.
Further, as shown in Table 5, there was no significant
differences in the prevalence of TTV, TTMDV, and
TTMV among the different ethnic or nationality groups
residing in Qatar, which further suggests that national-
ities or population origin has no effect on the prevalence
of these viruses in Qatar.
Discussion
Since their discovery, the three anelloviruses TTV,
TTMV, and TTMDV shared some common features
such as their detection in the blood of healthy donors
and in HBV/HCV pationts. The presence of the viruses
in non- A to G hepatitis patients, linked them to hepa-
titis. This probably justifies the number of studies, spe-
cially on TTV, that evaluated the prevalence of the virus
in HBV and HCV blood samples compared to the lim-
ited number of studies in healthy individuals especially
in the Middle East region. In a previous study [8] we re-
ported our finding concerning the prevalence of TTV in
healthy blood donors and HBV/HBC patients in Qatar.
Therefore, the objective of this study was to evaluate the
TTMV and TTMDV prevalence rates in healthy, as well
as, HBV and HCV subjects in Qatar and compare the
findings to those in the previous TTV study.
The current study was conducted on a total of 607
blood samples from healthy blood donors (n = 500), sub-
jects with HBV (n = 54) or HBC (n = 53). Findings of the
present study showed an overall high prevalence rates of
the three viruses (Fig. 1); TTV prevalence rates (85.2%t)
were significantly higher (p < 0.05) than the other two vi-
ruses (76.3 and 66.6% for TTMDV, and TTMV, respect-
ively). A closer comparative look at the ditribution of the
three viruses in the different study groups (healthy,
HBV, and HCV) revealed interesting findings. Firstly, the
incidences of the three viruses were significantly high in
the HBV and HCV groups as compared to the healthy
group (p < 0.05) (Table 2); prevalence rates were even
highre in the HBV group (reaching 98% in the HBV
group for TTMDV). Secondly, the prevalence rates of
the three viruses were significantly different in the
healthy (p < 0.001) and HBV (p < 0.04) groups but not in
the HCV group (Table 2).
Further, most of the tested samples, regarless of the
study group, yielded mixed infections; the highest associ-
ation was seen in the HBV group between TTV and
TTMV (96.3% of the samples); most of the associations
were significant (p < 0.05) except for the mixed TTV/
TTMDV infecitons in the HBV group and TTMDV/
TTMV mixed infections in the HCV group (Table 3).
Prevalence rates for the three viruses were not signifi-
cantly different in relation to gender, nationality or age
(Table 4) (p > 0.05), albeit the slightly higher infection
rates in females and Qatari nationals. A closer look at
the overall distribution of the viruses in different ethnic
backgrounds as compared to Qatari nationals revealed
higher rates in Qataris and “others” compared to Asians
and Africans (p > 0.05) (Table 5).
There is great prevalence variation of anelloviruses in
different regions of the world. This variability can be ex-
plained in different ways; it is probably a true represen-
tation of the ubiquity of the viruses; it can be also
attributed to the choice of DNA target region amplified
and PCR primers used.
The high prevalence rates of anelloviruses viremias in
this study, and other studies for that matter, can be also
Table 2 TTV, TTMV, and TTMDV distribution in study groups
Healthy (n = 500)
n (%)
HBV (n = 54)
n (%)
p-value * HCV (n = 53)
n (%)
p-value**
TTV 417 (83.4) 52 (96.3) <0.01 46 (86.8) 0.52
TTMDV 373 (74.6) 53 (98.1) <0.001 47 (88.7) 0.02
TTMV 306 (61.2) 46 (85.2) <0.001 44 (83.0) <0.001
*** p-value <0.001 0.04 0.69
* Healthy vs HBV, ** Healthy vs HCV, *** TTV vs TTMDV vs TTMV
Table 3 Association between TTV, TTMV, and TTMDV in
different study populations
TTMDV n (%) p-value TTMV n (%) p -value
Healthy (n = 500) TTV 336 (67.2) <0.001 277 (55.4) <0.001
TTMDV − − 277 (55.4) <0.001
HBV (n = 54) TTV 46 (85.2) 0.14 52 (96.3) 0.03
TTMDV − − 46 (85.2) 0.02
HCV (n = 53) TTV 41 (77.4) 0.05 43 (81.1) 0.02
TTMDV − − 39 (73.6) 0.33
Al-Qahtani et al. Virology Journal  (2016) 13:208 Page 4 of 6
explained in part, by the ease of transmission of the
virus.
Compared to TTV, much less is known about the
prevalence rates of the TTMV and TTMDV in healthy
individuals, as well as HBV and HBC patients. Earlier re-
ports on the prevalence of TTMV in other regions indi-
cated comperable infection rates in blood donors from
France (76–77%) [9], Brazil (72–77%) [10, 11] and
Norway (48%) [12]. Furthermore, lower prevalence rates
were previously reported in healthy blood donors in
Korea (41.3%) [25] and Iran (17%) [26].
With regards to TTMDV, the viremia frequency of the
virus in healthy individuals was 14.5% in Iran [19], 34.5%
in Korea [27], 20% in France [27], and 8.6% in Italian
blood donors [18]. Those findings are much lower than
the 74.6% reported in the current study in Qatar.
Due to the scarcity of data regarding the incidence of
TTMV and TTMDV in HBV- or HCV-positive subjects,
it became more difficult to make any comparative ana-
lysis. An earlier study in Iran reported incidence rate of
20% (5/25) and 48% (12/25) of TTMV in HBV and HCV
subjects [26]. Further, Garcia-Alvarez et al. reported a
very high incidence rate of TTV and TTMV in HIV/
HCV-coinfected patients, which is higher than the 83%
infection rate in HCV patients in the current study [28].
Also, in another study in Iran, researchers reported a
TTMDV incidence rate of 80.5% (29/36) and 75% (3/4)
in HIV/HCV and HIV/HCV/HBV coinfected patients,
respectively [19], which was lower than the 88.7 and
98.1% TTMDV infection rates obtained in HCV and
HBV infected patients in the current study (Table 2).
High frequencies of TTMV and TTMDV among HBV
and HBC patients in comparison to low frequencies in
healthy blood donors suggest common infection routes,
highly compatible with these viruses, such as blood and
sex.
Moreover, coinfection with multiple TT viruses seems
to be a common event [28–30]. One explanation for the
mixed infections with different anelloviruses seen in the
current study and other studies would be that the viruses
may have similar and probably synergystic infection cycles
that help viruses from the same family better adapt to the
environment. Another explanation would be that these vi-
ruses probably infect the same cell types permitting the vi-
ruses to favorably replicate in the same cells.
Conclusions
In conclusion, this study showed a high prevalence
(>75%) of the three anelloviruses (TTV, TTMDV, and
TTMV) in the Middle East. Further studies are needed
to explore and compare the different genotypes of these
viruses in the region.
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